No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects
-
Bone Neoplasms / drug therapy*
-
Bone Neoplasms / secondary
-
Humans
-
Lung Neoplasms / chemically induced*
-
Lung Neoplasms / surgery
-
Lymphatic Metastasis
-
Melanoma / drug therapy*
-
Melanoma / pathology
-
Multiple Pulmonary Nodules / chemically induced*
-
Multiple Pulmonary Nodules / surgery
-
Pneumonia / chemically induced*
-
Pneumonia / surgery
-
Prognosis
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / secondary
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
pembrolizumab